Clinical Trial Update: Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cytokine-induced killer cell immunotherapy after chemotherapy in surgically resected stage III colorectal cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cytokine-induced killer cell immunotherapy

Snippet

Sponsor: Sun Yat-sen University | Conditions: Stage III Colon Cancer | Phase 3 | Status: UNKNOWN